Literature DB >> 26753490

Interleukin-6 and C-reactive protein levels in the amniotic fluid as indicators of preterm delivery in Turkish women.

M Öz, B Polat, E Özgü, K D Seçkin, C Taşin, N Danişman.   

Abstract

OBJECTIVE: The aim of this study was to determine the value of amniotic fluid interleukin-6 (IL-6) and C-reactive protein (CRP) levels in the prediction of preterm delivery in singleton pregnancies without any known risk factors for preterm delivery in Turkish women.
MATERIALS AND METHODS: Patients in the present perinatology department who underwent mid-trimester genetic amniocentesis due to evidence of increased risk of aneuploidy in their prenatal serum screening tests were included in the study. A sample of amniotic fluid from each patient was assessed for IL-6 and CRP. Concentrations of IL-6 and CRP in the amniotic fluid of preterm delivery and term delivery groups were compared.
RESULTS: Of 151 singleton pregnancies, 142 participants were included in the study. The participants were assigned to either the preterm or term delivery group based on pregnancy outcome. IL-6 levels in the amniotic fluid were significantly higher in the preterm delivery group, and there was a statistically significant negative correlation between IL-6 concentrations in the amniotic fluid and gestational age at delivery (correlation coefficient (CC): -18.5%, p < 0.05). A negative correlation was also detected between CRP levels in the amniotic fluid and gestational age at delivery, but the correlation was not statistically significant (p = 0.068).
CONCLUSION: Measuring IL-6 in the amniotic fluid can identify women at risk of preterm delivery. Because it is not acceptable to perform amniocentesis for this screening, it is more convenient for patients in whom genetic amniocentesis is performed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26753490

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  5 in total

1.  Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection/inflammation presenting with cervical insufficiency.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; JoonHo Lee; Agustin Conde-Agudelo; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2019-03-28       Impact factor: 8.661

2.  Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes.

Authors:  Tarja Myntti; Leena Rahkonen; Irmeli Nupponen; Anu Pätäri-Sampo; Minna Tikkanen; Timo Sorsa; Juuso Juhila; Sture Andersson; Jorma Paavonen; Vedran Stefanovic
Journal:  Dis Markers       Date:  2017-01-12       Impact factor: 3.434

Review 3.  Prediction of Preterm Birth: Maternal Characteristics, Ultrasound Markers, and Biomarkers: An Updated Overview.

Authors:  Zeynep Asli Oskovi Kaplan; A Seval Ozgu-Erdinc
Journal:  J Pregnancy       Date:  2018-10-10

4.  Neuromedin B mediates IL-6 and COX-2 expression through NF-κB/P65 and AP-1/C-JUN activation in human primary myometrial cells.

Authors:  Texuan Zhu; Jingfei Chen; Yanhua Zhao; Jiejie Zhang; Qiaozhen Peng; Jingrui Huang; Jiefeng Luo; Weishe Zhang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

5.  Neuromedin B receptor mediates neuromedin B-induced COX-2 and IL-6 expression in human primary myometrial cells.

Authors:  Jingfei Chen; Yun Shi; Jingrui Huang; Jiefeng Luo; Weishe Zhang
Journal:  J Investig Med       Date:  2020-07-21       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.